We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cognizant (CTSH) Accelerates Generative AI Adoption at Scale
Read MoreHide Full Article
Cognizant Technology Solutions’ (CTSH - Free Report) generative AI technology experienced a recent breakthrough. The company is offering the facility of fundamentally transforming clients' businesses. It has been accelerating its investment in generative AI to enhance its own creativity and productivity.
To deploy generative AI at enterprise scale, Cognizant announced a new AI platform, Cognizant Neuro, designed to provide enterprises with a comprehensive approach to accelerate the adoption of generative AI technology and channel its business value in a flexible, secure, scalable and responsible way.
The Cognizant Neuro AI platform helps identify company specific-use cases and operationalizing AI to data engineering and continuous improvement. It includes a library of reusable and flexible generative AI models and agents, development tooling and control components.
The platform leverages Cognizant's consulting, advisory, ecosystem partnership, digital studios, solutioning, and delivery capabilities, in conjunction with industry expertise, to help clients transition into generative AI.
Cognizant Technology Solutions Corporation Price and Consensus
Cognizant rides on a strong partner base with the likes of Amazon (AMZN - Free Report) , Microsoft (MSFT - Free Report) and Alphabet (GOOGL - Free Report) that enhances Cognizant’s AI and cloud solutions to accelerate digital transformation and expand clientele.
Cognizant works with Amazon to build a robust digital platform on AWS Cloud driving transformative cloud innovation. It aims to provide richer customer experiences through three core capabilities — Cloud Consult, Cloud Migrate and Cloud Operate.
Microsoft and Cognizant collaborated to integrate Cognizant's TriZetto healthcare products with Microsoft Cloud for Healthcare, giving healthcare payers and providers easy access to cutting-edge technology solutions and improving interoperability to optimize business operations.
Cognizant and Google Cloud expanded their partnership to accelerate enterprises' application of generative AI with more highly-skilled AI experts, new solutions focused on creating business value and deep experience. It provides a suite of transformative solutions for all industries, leveraging Google Cloud's generative AI, predictive AI and analytics capabilities.
Cognizant’s Prospects not so Bright
Shares of Cognizant have increased 9.8% year to date compared with the Zacks Computer and Technology sector’s increase of 21.8% in the same time frame.
The recent underperformance in Cognizant’s shares reflects slowing growth primarily due to stiff competition, challenging macroeconomic conditions and unfavourable forex.
This Zacks Rank #4 (Sell) company expects second-quarter 2023 revenues between $4.83 billion and $4.88 billion, indicating a year-over-year decline of 1% to flat on a constant-currency basis. Unfavourable forex is expected to hurt the top line by 60 bps while acquisitions are expected to contribute 100 bps. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for fiscal second-quarter revenues is pegged at $4.8 billion, indicating a decline of 2.08% from the year-ago quarter’s reported figure.
The consensus mark for earnings has remained unchanged at $1 per share in the past 30 days, indicating a year-over-year fall of 12.28%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Cognizant (CTSH) Accelerates Generative AI Adoption at Scale
Cognizant Technology Solutions’ (CTSH - Free Report) generative AI technology experienced a recent breakthrough. The company is offering the facility of fundamentally transforming clients' businesses. It has been accelerating its investment in generative AI to enhance its own creativity and productivity.
To deploy generative AI at enterprise scale, Cognizant announced a new AI platform, Cognizant Neuro, designed to provide enterprises with a comprehensive approach to accelerate the adoption of generative AI technology and channel its business value in a flexible, secure, scalable and responsible way.
The Cognizant Neuro AI platform helps identify company specific-use cases and operationalizing AI to data engineering and continuous improvement. It includes a library of reusable and flexible generative AI models and agents, development tooling and control components.
The platform leverages Cognizant's consulting, advisory, ecosystem partnership, digital studios, solutioning, and delivery capabilities, in conjunction with industry expertise, to help clients transition into generative AI.
Cognizant Technology Solutions Corporation Price and Consensus
Cognizant Technology Solutions Corporation price-consensus-chart | Cognizant Technology Solutions Corporation Quote
Cognizant Leveraging on Strong Partnerships
Cognizant rides on a strong partner base with the likes of Amazon (AMZN - Free Report) , Microsoft (MSFT - Free Report) and Alphabet (GOOGL - Free Report) that enhances Cognizant’s AI and cloud solutions to accelerate digital transformation and expand clientele.
Cognizant works with Amazon to build a robust digital platform on AWS Cloud driving transformative cloud innovation. It aims to provide richer customer experiences through three core capabilities — Cloud Consult, Cloud Migrate and Cloud Operate.
Microsoft and Cognizant collaborated to integrate Cognizant's TriZetto healthcare products with Microsoft Cloud for Healthcare, giving healthcare payers and providers easy access to cutting-edge technology solutions and improving interoperability to optimize business operations.
Cognizant and Google Cloud expanded their partnership to accelerate enterprises' application of generative AI with more highly-skilled AI experts, new solutions focused on creating business value and deep experience. It provides a suite of transformative solutions for all industries, leveraging Google Cloud's generative AI, predictive AI and analytics capabilities.
Cognizant’s Prospects not so Bright
Shares of Cognizant have increased 9.8% year to date compared with the Zacks Computer and Technology sector’s increase of 21.8% in the same time frame.
The recent underperformance in Cognizant’s shares reflects slowing growth primarily due to stiff competition, challenging macroeconomic conditions and unfavourable forex.
This Zacks Rank #4 (Sell) company expects second-quarter 2023 revenues between $4.83 billion and $4.88 billion, indicating a year-over-year decline of 1% to flat on a constant-currency basis. Unfavourable forex is expected to hurt the top line by 60 bps while acquisitions are expected to contribute 100 bps. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for fiscal second-quarter revenues is pegged at $4.8 billion, indicating a decline of 2.08% from the year-ago quarter’s reported figure.
The consensus mark for earnings has remained unchanged at $1 per share in the past 30 days, indicating a year-over-year fall of 12.28%.